Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 071026
Company: FRONTIDA BIOPHARM
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
OXAZEPAM OXAZEPAM 30MG CAPSULE;ORAL Discontinued None No No
OXAZEPAM OXAZEPAM 10MG CAPSULE;ORAL Discontinued None No No
OXAZEPAM OXAZEPAM 15MG CAPSULE;ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/10/1987 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/16/2016 SUPPL-17 Labeling-Medication Guide, Labeling-Package Insert

Label is not available on this site.

12/01/1998 SUPPL-11 Manufacturing (CMC)

Label is not available on this site.

12/23/1994 SUPPL-10 Manufacturing (CMC)

Label is not available on this site.

10/05/1993 SUPPL-9 Labeling

Label is not available on this site.

04/03/1992 SUPPL-8 Manufacturing (CMC)

Label is not available on this site.

04/03/1992 SUPPL-6 Manufacturing (CMC)

Label is not available on this site.

04/19/1989 SUPPL-5 Labeling

Label is not available on this site.

01/25/1988 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

01/25/1988 SUPPL-3 Manufacturing (CMC)

Label is not available on this site.

01/25/1988 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English